Jonathan I. Lieber

Insider Reports History

Entity: Individual
Location: C/O Histogenics Corporation, 830 Winter Street #3, Waltham, Massachusetts
Signature: /s/Mark Rosenblum, as Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Rallybio Corp	Chief Financial Officer	Option (Right to Buy)	120K	$212K	$1.77	Feb 15, 2024	Direct
Rallybio Corp	Chief Financial Officer	Common Stock	5K	$41K	$8.20	Mar 14, 2023	Direct
Salarius Pharmaceuticals, Inc.	Director	Stock Option (right to buy)	20.5K			Feb 20, 2024	Direct
APPLIED GENETIC TECHNOLOGIES CORP	Chief Financial Officer	Stock Option (Right to Buy)	0			Nov 30, 2022	Direct

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
SLRX	Salarius Pharmaceuticals, Inc.	Feb 20, 2024	1	$0	4	Feb 22, 2024	Director
RLYB	Rallybio Corp	Feb 15, 2024	1	$0	4	Feb 16, 2024	Chief Financial Officer
RLYB	Rallybio Corp	Mar 14, 2023	1	$26.1K	4	Mar 16, 2023	Chief Financial Officer and Treasurer
RLYB	Rallybio Corp	Feb 1, 2023	1	$0	4	Feb 1, 2023	Chief Financial Officer and Treasurer
RLYB	Rallybio Corp	Feb 1, 2023	0	$0	3	Feb 1, 2023	Chief Financial Officer and Treasurer Exhibit List: Exhibit 24 - Power of Attorney
SLRX	Salarius Pharmaceuticals, Inc.	Jan 3, 2023	1	$0	4	Jan 5, 2023	Director
AGTC	APPLIED GENETIC TECHNOLOGIES CORP	Nov 30, 2022	2	$0	4	Dec 1, 2022	Chief Financial Officer
AGTC	APPLIED GENETIC TECHNOLOGIES CORP	Aug 21, 2022	1	$0	4	Aug 24, 2022	Chief Financial Officer
SLRX	Salarius Pharmaceuticals, Inc.	Jun 7, 2022	1	$7.02K	4	Jun 8, 2022	Director
SLRX	Salarius Pharmaceuticals, Inc.	Jan 20, 2022	1	$0	4	Jan 21, 2022	Director
AGTC	APPLIED GENETIC TECHNOLOGIES CORP	Sep 20, 2021	1	$0	4	Sep 21, 2021	Chief Financial Officer
AGTC	APPLIED GENETIC TECHNOLOGIES CORP	Sep 20, 2021	0	$0	3	Sep 21, 2021	Chief Financial Officer